Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Appointment Extends Freeman Technology’s Applications Team

Published: Monday, April 22, 2013
Last Updated: Monday, April 22, 2013
Bookmark and Share
Powder characterization company Freeman Technology has appointed Doug Millington-Smith in the role of Applications Specialist.

Educated to PhD level, Doug has a background in chemistry and considerable experience in supporting the use of high precision scientific instrumentation. He is based at Freeman Technology’s headquarters in the UK and will be involved in supporting users of the FT4 Powder Rheometer® right through from initial installation and training to ongoing education and applications support.
 
Welcoming Doug to the team, Managing Director Tim Freeman said: “FT4 users around the world know they can call on the expertise and experience both of our representatives on the ground and the team working at our UK headquarters, where we continue to invest strongly in our R&D and applications support. The FT4 Powder Rheometer is now used in a diverse range of industrial situations and we are growing our teams to ensure that we continue to develop the customer support excellence for which we are known.”
 
Doug Millington-Smith will be involved in installing Instruments at user sites and providing initial user training. Users will then be able to turn to him for remote advice and continued support in all areas including analysis and data interpretation if needed.
 
“The fact that Freeman Technology demonstrates the potential of its products through meaningful research makes it a very attractive company to work for,” said Doug. “I am delighted to now be part of such a successful team and am enjoying helping people across many different areas of powder characterization to make the most of their experience with our instruments.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!